Smith AL - Search Results

1

Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients.

Ramsey BW, Wentz KR, Smith AL, Richardson M, Williams-Warren J, Hedges DL, Gibson R, Redding GJ, Lent K, Harris K. Ramsey BW, et al. Among authors: smith al. Am Rev Respir Dis. 1991 Aug;144(2):331-7. doi: 10.1164/ajrccm/144.2.331. Am Rev Respir Dis. 1991. PMID: 1859056

2

Clinical manifestations and treatment of pulmonary infections in cystic fibrosis.

Burns JL, Ramsey BW, Smith AL. Burns JL, et al. Among authors: smith al. Adv Pediatr Infect Dis. 1993;8:53-66. Adv Pediatr Infect Dis. 1993. PMID: 8217005 Review. No abstract available.

3

Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis.

Smith AL, Ramsey BW, Hedges DL, Hack B, Williams-Warren J, Weber A, Gore EJ, Redding GJ. Smith AL, et al. Pediatr Pulmonol. 1989;7(4):265-71. doi: 10.1002/ppul.1950070413. Pediatr Pulmonol. 1989. PMID: 2515523 Clinical Trial.

4

The effect of respiratory viral infections on patients with cystic fibrosis.

Ramsey BW, Gore EJ, Smith AL, Cooney MK, Redding GJ, Foy H. Ramsey BW, et al. Among authors: smith al. Am J Dis Child. 1989 Jun;143(6):662-8. doi: 10.1001/archpedi.1989.02150180040017. Am J Dis Child. 1989. PMID: 2543212

5

Endobronchial infection in cystic fibrosis.

Smith AL, Ramsey B, Redding G, Haas J. Smith AL, et al. Acta Paediatr Scand Suppl. 1989;363:31-6. doi: 10.1111/apa.1989.78.s363.31. Acta Paediatr Scand Suppl. 1989. PMID: 2701922 Review.

6

Tobramycin Serum Concentrations After Aerosol and Oral Administration in Cystic Fibrosis.

Weber A, Williams-Warren J, Ramsey B, Smith AL. Weber A, et al. Among authors: smith al. Am J Ther. 1995 Feb;2(2):81-87. doi: 10.1097/00045391-199502000-00002. Am J Ther. 1995. PMID: 11847533

7

Defining a pulmonary exacerbation in cystic fibrosis.

Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B. Rosenfeld M, et al. J Pediatr. 2001 Sep;139(3):359-65. doi: 10.1067/mpd.2001.117288. J Pediatr. 2001. PMID: 11562614 Clinical Trial.

8

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis.

Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW. Rosenfeld M, et al. Pediatr Pulmonol. 2001 Nov;32(5):356-66. doi: 10.1002/ppul.1144. Pediatr Pulmonol. 2001. PMID: 11596160

9

Probenecid pharmacokinetics in cystic fibrosis.

Weber A, de Groot R, Ramsey B, Williams-Warren J, Smith A. Weber A, et al. Dev Pharmacol Ther. 1991;16(1):7-12. Dev Pharmacol Ther. 1991. PMID: 1879255

10

Nebulizer delivery of tobramycin to the lower respiratory tract.

Weber A, Smith A, Williams-Warren J, Ramsey B, Covert DS. Weber A, et al. Pediatr Pulmonol. 1994 May;17(5):331-9. doi: 10.1002/ppul.1950170511. Pediatr Pulmonol. 1994. PMID: 8058428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,364 results

Search Page

Filters